This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chatterjee, S. K. Articles by Bhattacharya-Chatterjee, M. Search for Related Content PubMed PubMed Citation Articles by Chatterjee, S. K. Articles by Bhattacharya-Chatterjee, M.

Molecular Mimicry of Carcinoembryonic Antigen by Peptides Derived from the Structure of an Anti-Idiotype Antibody¹

Department of Internal Medicine, Division of Hematology and Oncology [S. K. C., P. K. T., M. C., J. Y., K. A. F., M. B-C.], Department of Microbiology and Immunology [H. W.], and Lucille Parker Markey Cancer Center, University of Kentucky Medical Center, [S. K. C., P. K. T., M. C., J. Y., H. W., K. A. F., M. B.-C.], Lexington, Kentucky 40536-0096; and Department of Physiology and Biophysics, University of Alabama, Birmingham, Alabama 35294 [C. C. M., J. E. B.]

Our goal was to use carcinoembryonic antigen (CEA) as a target for immunotherapy in CEA-positive cancer patients who are all immune tolerant to the native antigen. We isolated and characterized an anti-idiotype monoclonal antibody 3H1, which mimics a distinct and specific epitope of the M_r 180,000 CEA and can be used as a surrogate for CEA. In Phase Ib clinical trials in a group of 23 advanced colorectal cancer patients, 3H1 induced both humoral and cellular anti-3H1 responses, as well as anti-CEA immunity. To study the cellular immunity invoked by 3H1 at the molecular level, we have cloned and sequenced the cDNAs encoding the variable heavy and light chains of 3H1 and deduced the amino acid sequences of the encoded proteins. To identify any cross-reactive peptides of 3H1 and CEA, we compared the amino acid sequences of 3H1 with those of CEA and found several regions of homology in 3H1 heavy and light chain variable domains, as well as in the framework regions. To search for potential cross-reactive T-cell epitopes, a number of peptides were synthesized based on 3H1/CEA homology and were used as stimulants in cell proliferation assays, using peripheral blood mononuclear cells from a group of 3H1-immunized CEA-positive cancer patients in the adjuvant setting. Two partially homologous peptides, designated LCD-2 (from 3H1) and CEA-B (from CEA), were identified in 10 of 21 adjuvant patients by strong proliferation responses (stimulation index, 3–50-fold), which were extensively studied in five of these individuals over an extended period of time (12–24 months). We saw no correlation with the MHC class I haplotype of the patients. Analysis of the subtype of the responding T cells demonstrated that primarily CD4⁺ T cells were stimulated by both 3H1 and 3H1-derived peptides. Interleukin 2, interleukin 4, and IFN- were assayed in the culture medium of peripheral blood mononuclear cells stimulated with 3H1, CEA, and LCD-2 to determine the T-cell helper subset induced by these stimulants. The in vitro responses were mainly associated with secretion of IFN-, which suggested that the induced T cells were most likely CD4⁺ Th1 type. Future studies will include the design of second-generation LCD-2 and CEA peptides to further enhance antigenicity, to characterize the responding T-cell populations more fully, and to test refined peptides for immunogenicity.

¹ This work was supported in part by NIH Grants RO1 CA72773, RO3 CA72468, and PO1 NS29719.

² To whom requests for reprints should be addressed, at 204 Combs Cancer Research Building, University of Kentucky Medical Center, 800 Rose Street, Lexington, KY 40536-0096.

Received 9/17/97. Accepted 1/16/98.

This article has been cited by other articles:

				K. Kawano, S. Ferrone, and C. G. Ioannides Functional Idiotopes: Tumor Antigen-Directed Expression of CD8+ T-Cell Epitopes Nested in Unique NH2-terminal VH Sequence of Antiidiotypic Antibodies? Cancer Res., July 15, 2005; 65(14): 6001 - 6004. [Abstract] [Full Text] [PDF]

				J. L. Murray, M. Gillogly, K. Kawano, C. L. Efferson, J. E. Lee, M. Ross, X. Wang, S. Ferrone, and C. G. Ioannides Fine Specificity of High Molecular Weight-Melanoma-Associated Antigen-Specific Cytotoxic T Lymphocytes Elicited by Anti-Idiotypic Monoclonal Antibodies in Patients with Melanoma Cancer Res., August 1, 2004; 64(15): 5481 - 5488. [Abstract] [Full Text] [PDF]

				A. Saha, S. K. Chatterjee, K. A. Foon, F. J. Primus, S. Sreedharan, K. Mohanty, and M. Bhattacharya-Chatterjee Dendritic Cells Pulsed with an Anti-Idiotype Antibody Mimicking Carcinoembryonic Antigen (CEA) Can Reverse Immunological Tolerance to CEA and Induce Antitumor Immunity in CEA Transgenic Mice Cancer Res., July 15, 2004; 64(14): 4995 - 5003. [Abstract] [Full Text] [PDF]

				A. Saha, S. K. Chatterjee, K. A. Foon, F. J. Primus, and M. Bhattacharya-Chatterjee Murine Dendritic Cells Pulsed with an Anti-Idiotype Antibody Induce Antigen-specific Protective Antitumor Immunity Cancer Res., June 1, 2003; 63(11): 2844 - 2854. [Abstract] [Full Text] [PDF]

				K. A. Foon and M. Bhattacharya-Chatterjee Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time?: Commentary re: U. Wagner et al., Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment. Clin. Cancer Res., 7: 1154-1162, 2001. Clin. Cancer Res., May 1, 2001; 7(5): 1112 - 1115. [Full Text]

				N.-K. V. Cheung, H.-f. Guo, G. Heller, and I. Y. Cheung Induction of Ab3 and Ab3' Antibody Was Associated with Long-Term Survival after Anti-GD2 Antibody Therapy of Stage 4 Neuroblastoma Clin. Cancer Res., July 1, 2000; 6(7): 2653 - 2660. [Abstract] [Full Text]

				L. G. Durrant, C. Maxwell-Armstrong, D. Buckley, S. Amin, R. A. Robins, J. Carmichael, and J. H. Scholefield A Neoadjuvant Clinical Trial in Colorectal Cancer Patients of the Human Anti-Idiotypic Antibody 105AD7, Which Mimics CD55 Clin. Cancer Res., February 1, 2000; 6(2): 422 - 430. [Abstract] [Full Text]

				K. A. Foon, W. J. John, M. Chakraborty, R. Das, A. Teitelbaum, J. Garrison, O. Kashala, S. K. Chatterjee, and M. Bhattacharya-Chatterjee Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic Antigen J. Clin. Oncol., September 1, 1999; 17(9): 2889 - 2889. [Abstract] [Full Text] [PDF]

				I. Spendlove, L. Li, J. Carmichael, and L. G. Durrant Decay Accelerating Factor (CD55): A Target for Cancer Vaccines? Cancer Res., May 1, 1999; 59(10): 2282 - 2286. [Abstract] [Full Text] [PDF]

				K. A. Foon, J. Yannelli, and M. Bhattacharya-Chatterjee Colorectal Cancer as a Model for Immunotherapy Clin. Cancer Res., February 1, 1999; 5(2): 225 - 236. [Full Text] [PDF]